GABRIELLA FURFARI: Open Payments
NPI 1760993018 · MEDINA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,464 in 125 payments from 17 companies in 2025. Trend: 2023 $2,038 · 2024 $2,549 · 2025 $2,464
Food & beverage: $2,304Education: $160
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $435 |
| UCB, Inc. | 12 | $303 |
| Amgen Inc. | 12 | $231 |
| Novartis Pharmaceuticals Corporation | 12 | $206 |
| Organon LLC | 12 | $204 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $204 |
| Regeneron Healthcare Solutions, Inc. | 6 | $200 |
| E.R. Squibb & Sons, L.L.C. | 10 | $177 |
| Janssen Biotech, Inc. | 7 | $152 |
| Lilly USA, LLC | 5 | $88 |
Products named: Bimzelx, SKYRIZI, DUPIXENT, OTEZLA, Sotyktu, TREMFYA, COSENTYX, RINVOQ.
Industry payments across OH — which companies pay providers there.
